ЕВРА

ਉਤਪਾਦ ਝਲਕ

About EVRA

EVRA — KONTRATsEPTYVNYI medicine, is intended for prevention ZAPLIDNENNIu in ZhINOK REPRODUKTYVNOHO VIKU. Its efficacy VSTANOVLENA only for ZhINOK aged 18–45 years.

Medicine contains NORELHESTROMIN and ETYNILESTRADIOL, which PRYHNIChUIuT HONADOTROPINIV by ESTROHENNOI and PROHESTAHENNOI action.

Composition

The composition of EVRA are contained NORELHESTROMIN (6 mg) and ETYNILESTRADIOL (0,6 mg). Excipients include ADHEZYVNU SUMISh POLIIZOBUTYLENU and POLIBUTENU, LAURYLLAKTAT and KROSPIDON.

Indications

EVRA is intended for KONTRATsEPTsII in ZhINOK. RIShENNIa about PRYZNAChENNIa medicine POVYNNO VRAKhOVUVATY POTOChNI FAKTORY RYZYKU for KOZhNOI ZhINKY, especially against VENOZNOI TROMBOEMBOLII.

Pharmacological properties

EVRA DIIe by INHIBUVANNIa OVULIaTsII and ZMINY TsERVIKALNOHO SLYZU and ENDOMETRIIa. Its efficacy PIDTVERDZhENA DOSLIDZhENNIaMY, which POKAZALY NYZKYI level VAHITNOSTI among ZhINOK, which ZASTOSOVUVALY this medicine.

Source: Compendium